Download Leukaemia Section t(3;6)(q27;q14) SNHG5/BCL6 Atlas of Genetics and Cytogenetics

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Zinc finger nuclease wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
INIST-CNRS
OPEN ACCESS JOURNAL
Leukaemia Section
Short Communication
t(3;6)(q27;q14) SNHG5/BCL6
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: November 2012
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t0306q27q14ID2133.html
DOI: 10.4267/2042/48763
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2013 Atlas of Genetics and Cytogenetics in Oncology and Haematology
SNHG5
Clinics and pathology
Location
6q14.3
Protein
SNHG5 is also known as U50HG. SNHG5 exons do
not encode a polypeptide product (small nucleolar
RNA (snoRNA) sequence). SNHG5 is composed of six
exons. It possesses an oligopyrimidine tract that is
characteristic of the 5'-terminal oligopyrimidine (5'TOP
gene family) which have been shown to regulate cell
growth.
Disease
Non Hodgkin lymphoma
Clinics
The t(3;6)(q27;q14) was found in a human diffuse large
B-cell lymphoma cell line (Tanaka et al., 2000), and in
a case of follicular lymphoma transformed to diffuse
aggressive lymphoma, from a study with no individual
data (Akasaka et al., 2003).
Genes involved and proteins
Result of the chromosomal
anomaly
BCL6
Location
3q27.3
Protein
706 amino acids; composed of a NH2-term BTB/POZ
domain (amino acids 1-130 (32-99 according to SwissProt) which mediates homodimerization and proteinprotein interactions with other corepressors (including
HDAC1 and NCOR2/SMRT to constitute a large
repressing complex, another transcription repression
domain (191-386), PEST sequences (300-417) with a
KKYK motif (375-379), and six zinc finger at the Cterm (518-541, 546-568, 574-596, 602-624, 630-652,
658-681), responsible for sequence specific DNA
binding. Transcription repressor; recognizes the
consensus sequence: TTCCT(A/C)GAA (AlbagliCuriel, 2003). Role in germinal centers of lymphoid
follicles. BCL6 prevents ATM and TP53 to induce
apoptosis in response to DNA rearrangements such as
somatic hypermutation and class switch recombination.
Therefore essential for normal B cell development.
Atlas Genet Cytogenet Oncol Haematol. 2013; 17(3)
Hybrid gene
Description
Breakpoint in BCL6 first intron.
References
Tanaka R, Satoh H, Moriyama M, Satoh K, Morishita Y,
Yoshida S, Watanabe T, Nakamura Y, Mori S. Intronic U50
small-nucleolar-RNA (snoRNA) host gene of no protein-coding
potential is mapped at the chromosome breakpoint
t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells. 2000
Apr;5(4):277-87
Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in
follicular lymphoma: a harbinger of eventual transformation to
diffuse
aggressive
lymphoma.
Blood.
2003
Aug
15;102(4):1443-8
Albagli-Curiel O. Ambivalent role of BCL6 in cell survival and
transformation. Oncogene. 2003 Jan 30;22(4):507-16
This article should be referenced as such:
Huret JL. t(3;6)(q27;q14) SNHG5/BCL6.
Cytogenet Oncol Haematol. 2013; 17(3):203.
203
Atlas
Genet
Related documents
Leukaemia Section t(3;3)(q27;q28) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;3)(q27;q28) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;9)(q27;p24) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;9)(q27;p24) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;19)(q27;q13) NAPA/BCL6  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;19)(q27;q13) NAPA/BCL6 Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;3)(q25;q27) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;3)(q25;q27) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;3)(q27;q27) ST6GAL1/BCL6 / del(3)(q27q27) ST6GAL1/BCL6 Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;3)(q27;q27) ST6GAL1/BCL6 / del(3)(q27q27) ST6GAL1/BCL6 Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;6)(q27;p21) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;6)(q27;p21) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;9)(q27;p13) GRHPR/BCL6  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;9)(q27;p13) GRHPR/BCL6 Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;4)(q27;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;4)(q27;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;6)(q27;p22) HIST1H4I/BCL6 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;6)(q27;p22) HIST1H4I/BCL6 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;8)(q27;q24) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;8)(q27;q24) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;6)(q27;p21) PIM1/BCL6 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;6)(q27;p21) PIM1/BCL6 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;12)(q27;p12) LRMP/BCL6 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;12)(q27;p12) LRMP/BCL6 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section Diffuse large cell lymphoma Atlas of Genetics and Cytogenetics
Leukaemia Section Diffuse large cell lymphoma Atlas of Genetics and Cytogenetics
Transcriptional Deregulation of Mutated BCL6 Alleles by Loss of
Transcriptional Deregulation of Mutated BCL6 Alleles by Loss of
Press release - Fondation ULB
Press release - Fondation ULB
Leukaemia Section 3q27 rearrangements in non Hodgkin lymphoma,
Leukaemia Section 3q27 rearrangements in non Hodgkin lymphoma,
BCL-6, a POZ transcriptional repressor zinc-finger protein, is a sequence-specific C
BCL-6, a POZ transcriptional repressor zinc-finger protein, is a sequence-specific C
Gene Section BCL6 (B-Cell Lymphoma 6) Atlas of Genetics and Cytogenetics
Gene Section BCL6 (B-Cell Lymphoma 6) Atlas of Genetics and Cytogenetics
Point mutations in BCL6 DNA-binding domain reveal distinct
Point mutations in BCL6 DNA-binding domain reveal distinct
somatic hypermutation of the 5' noncoding region of the Frequent MARTINOrrI*t,
somatic hypermutation of the 5' noncoding region of the Frequent MARTINOrrI*t,
Chromosomal translocations deregulated BCL6
Chromosomal translocations deregulated BCL6
Transcriptional networks controlling B cell germinal center activities
Transcriptional networks controlling B cell germinal center activities